Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
47,194,179
-
Share change
-
+96,423
-
Total reported value
-
$5,032,045,297
-
Put/Call ratio
-
96%
-
Price per share
-
$106.74
-
Number of holders
-
331
-
Value change
-
+$8,653,634
-
Number of buys
-
163
-
Number of sells
-
158
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2018
As of 31 Mar 2018,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) was held by
331 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,194,179 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ARIEL INVESTMENTS, LLC, STATE STREET CORP, WELLS FARGO & COMPANY/MN, and GOLDMAN SACHS GROUP INC.
This page lists
331
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.